Modelling the prevalence and cost of back pain with neuropathic components in the general population.
about
The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatmentNeuropathic low back pain in clinical practiceDevelopment and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.Anatomical study of middle cluneal nerve entrapmentValidity and reliability of the Japanese version of the painDETECT questionnaire: a multicenter observational study.Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic reviewNeuropathic pain in patients with rotator cuff tears.A burden of illness study for neuropathic pain in EuropeAxial low back pain: one painful area--many perceptions and mechanisms.Brain morphological alternation in chronic pain patients with neuropathic characteristicsPatient Satisfaction with Spanish Pain Centers: Observational Study with More than 3,000 Patients.Alterations in endogenous opioid functional measures in chronic back painInjectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management.Tapentadol extended-release for treatment of chronic pain: a review.Epidemiology of neuropathic pain and its impact on quality of life.Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain.Chronic low back pain: pharmacological, interventional and surgical strategies.What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review.Prevalence of neuropathic features of back pain in clinical populations: implications for the diagnostic triage paradigm.Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.Prevalence and associations of neuropathic pain in a cohort of multi-ethnic Asian low back pain patients.Untangling nociceptive, neuropathic and neuroplastic mechanisms underlying the biological domain of back pain.Anatomical etiology of "pseudo-sciatica" from superior cluneal nerve entrapment: a laboratory investigation.Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms.Evaluation of quality of life and neuropathic pain in patients with low back pain using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire.Chronic Pain and Sleep Disorders in Primary Care.Screening for neuropathic characteristics in failed back surgery syndromes: challenges for guiding treatment.Proportion of neuropathic pain in the back region in chronic low back pain patients -a multicenter investigationEffectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study
P2860
Q26860844-C7C7B0C4-4825-473D-99DA-4D7A2BD0A019Q28073412-B098517F-BF40-4872-87C5-4EC189172E80Q33777193-5DFE5109-696C-4B00-848E-BB5ADDBA3A07Q33812533-280A2774-2281-4DCB-94F5-CF4D4F0C9D84Q35009803-3FD7FE27-5DC9-47D5-8CAF-1B542D028647Q35955249-56516C53-83B6-4DEC-B0EB-1AD62AE2274DQ36180651-BA25EB49-4C37-48A9-B7C0-FAA27E336508Q36857799-A8DE252C-45D0-4F98-8E35-054559AD1BBCQ36976502-F235B7D4-0D56-4953-8E0F-484F53C0D7D1Q37115766-D7E723DA-3085-4EEE-9331-A07E59927153Q37144383-44871263-CA18-4DCB-B75C-F21D12EF5826Q37165504-07E09D26-2EDD-465E-BBF6-4ACAA1367654Q37474355-243B7BE3-0F6D-4B1A-99AF-90E8EF4E708AQ37925605-4F146FDD-E393-49CF-9E04-C540DDC99510Q37991227-B4A611BF-E83B-4499-84ED-116E76656125Q38065255-2AA163CE-F1E5-43BC-A237-A1F605F9EA93Q38118585-13D7458A-F2BD-4EBD-8599-896B3E6400FDQ38151940-C220D733-69C0-4E2A-A312-71A9D3F8C4E7Q38198101-4BF8E1E6-789D-4D3E-AAFB-65233B2C9213Q38823614-D523C4A3-394F-4404-9B76-503B9A7EBD87Q40408514-4F913C8D-10FD-440D-AFAA-4C6B5A06BD4AQ44317779-FDE16295-2411-437E-BAAC-78405D166D26Q47140068-D58630CA-BE92-4D79-AA04-7A7D5C7E3FADQ47321593-1D4B62B3-4CF8-4B39-9609-4B6A6F61B3B4Q48056428-95887FF0-48D6-42B3-8DC5-4F4C7587C908Q48094022-520D5DB7-C026-44BB-AC9F-FE10044FA663Q52838139-479A4894-F901-46BD-A4CB-898EBE0C2D9EQ58590150-0668270C-1E25-4BCA-979E-531A0066954CQ58912037-A3D560D4-67F3-4509-83BA-314381901864
P2860
Modelling the prevalence and cost of back pain with neuropathic components in the general population.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Modelling the prevalence and c ...... nts in the general population.
@en
Modelling the prevalence and c ...... nts in the general population.
@nl
type
label
Modelling the prevalence and c ...... nts in the general population.
@en
Modelling the prevalence and c ...... nts in the general population.
@nl
prefLabel
Modelling the prevalence and c ...... nts in the general population.
@en
Modelling the prevalence and c ...... nts in the general population.
@nl
P2093
P2860
P1476
Modelling the prevalence and c ...... nts in the general population.
@en
P2093
Bernd Schweikert
Carsten O Schmidt
Christina M Wenig
Ralf Baron
Thomas Kohlmann
Thomas R Tölle
Ulrich Gockel
Uwe Schmidt
P2860
P304
P356
10.1016/J.EJPAIN.2008.12.003
P577
2009-02-06T00:00:00Z